Search - tctmd.com

Displaying 121 - 138 of 138

Sort: Relevancy | Date

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Yael L. Maxwell

June 20, 2012

News Daily News

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Yael L. Maxwell

June 01, 2012

News Daily News

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Yael L. Maxwell

June 01, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

NHLBI Stops High-Dose Niacin Trial Early Due to Lack of Efficacy

May 27, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Jason Kahn

April 21, 2011

News Daily News

Another Study Finds No Interaction Between PPIs and Clopidogrel

L.A. McKeown

January 27, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

Advertisement

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

NHLBI Stops High-Dose Niacin Trial Early Due to Lack of Efficacy

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Another Study Finds No Interaction Between PPIs and Clopidogrel

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content